Specialists of the Centers for the Control and Prevention of US Diseases found out that RNA vaccines against coronavirus provide a significantly higher immunity than transferred infection. This is reported in an article published in Morbidity and Mortality Weekly Report.
Researchers analyzed the data on hospitalization about seven thousand people. The number of unduccinated people with a positive test on COVID-19 more than three months before hospitalization due to re-infection, as well as the number of people who received the Pfizer or Moderna vaccine, who have not been diagnosed with COVID before they entered the hospital . Nevaactive adults approximately five times more often needed hospitalization than those who were vaccinated.
According to scientists, the results convincingly prove that vaccination provides better protection from COVID-19 than natural immunity. Data Analysis also found that among adults over 65 years old RNA vaccines are almost 20 times more efficient in preventing hospitalizations than immunity after suffering infection. Thus, RNA vaccines have an advantage, contributing to high levels of antibodies, whereas those who recover from COVID-19, the levels of antibodies are less, especially if they have observed light symptoms or asymptomatic infection.